ERVW-1 and HIV-1 infection: Additional evidence supporting the role of virus-incorporated ICAM-1 in HIV-1 infection include the diminished neutralizing activity of antibodies against Env [41], [46], [47] and the ability of ICAM-1 antibodies to block virus entry [40]–[42].